Bromofenofos

Bromofenofos is an organophosphate insecticide that was first registered for use in the United States in 1975. It is used to control a variety of insects, including aphids, mites, and whiteflies, on a wide range of crops.

Etymology[edit | edit source]

The term "Bromofenofos" is derived from its chemical structure, which includes a bromine atom (bromo-), a phenyl group (-fen-), and a phosphorus atom (-fos).

Chemical Properties[edit | edit source]

Bromofenofos is a colorless to yellow liquid with a mild odor. It is slightly soluble in water and readily soluble in most organic solvents. It is stable under normal storage conditions, but it can decompose when exposed to heat or light, producing toxic fumes of bromine and phosphorus oxides.

Toxicity[edit | edit source]

Like other organophosphates, Bromofenofos is highly toxic to humans and animals. It inhibits the enzyme acetylcholinesterase, which is essential for the proper functioning of the nervous system. Symptoms of exposure can include nausea, vomiting, diarrhea, abdominal cramps, headache, dizziness, weakness, confusion, and in severe cases, seizures, loss of consciousness, and death.

Environmental Impact[edit | edit source]

Bromofenofos is toxic to birds, fish, and bees. It can contaminate water bodies and harm aquatic life. It is also persistent in the environment, with a half-life of several weeks to months in soil and water.

Regulation[edit | edit source]

Due to its high toxicity and environmental persistence, the use of Bromofenofos has been restricted in many countries. In the United States, it was cancelled for all uses in 1989.

Related Compounds[edit | edit source]

Other organophosphate insecticides include Malathion, Parathion, and Chlorpyrifos.

See Also[edit | edit source]

Bromofenofos Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.